Document Detail


Radiofrequency ablation for pulmonary metastases from esophageal squamous cell carcinoma.
MedLine Citation:
PMID:  23384275     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Radiofrequency ablation (RFA) is increasingly being used for the treatment of intrathoracic malignancies. Although RFA has been found to be promising in the treatment of lung metastases from some types of neoplasms, little is known concerning its clinical significance in the treatment of pulmonary metastasis from esophageal squamous cell carcinoma (ESCC). This retrospective study evaluated the feasibility, safety, and effectiveness of computed tomography-guided RFA for pulmonary metastasis from ESCC. A series of 10 ESCC patients with 17 pulmonary tumors were included. Correct placement of the ablation device into the target tumor proved to be feasible in all tumors (100%). The mean visual analog scale score, with values that ranged from 0 (no pain) to 10 (worst pain possible), was 1. This suggested that this procedure was well tolerated. No procedure-related deaths occurred. A pneumothorax needing drainage was a major complication in two patients. Local control of ablated tumor lasting for at least 1 year was achieved in 10 (83%) of 12 assessable tumors. Although locoregional recurrences developed in two tumors, these lesions could be recontrolled by repeat treatment with RFA. Three patients died of recurrent disease. The predicted 1- and 2-year overall survival rates after lung RFA were 77.8% and 62.2%, respectively. Percutaneous computed tomography-guided RFA yielded relatively high levels of local control in patients with pulmonary metastases from ESCC and was associated with an acceptable level of complications. It was concluded that a prospective study will be necessary to evaluate the effectiveness of a combination of systemic therapy and RFA for ESCC lung metastases.
Authors:
Y Baba; M Watanabe; K Kawanaka; S Iwagami; T Ishimoto; M Iwatsuki; N Yoshida; Y Yamashita; H Baba
Related Documents :
2550385 - Tumor volume and treatment outcome in small cell lung carcinoma.
20368715 - Tumor response is predicted by patient genetic profile in rectal cancer patients treate...
3338025 - Interval-by-interval cox model analysis of 3680 cases of intraocular melanoma shows a d...
19701705 - Pik3ca expression in invasive breast cancer: a biomarker of poor prognosis.
2550385 - Tumor volume and treatment outcome in small cell lung carcinoma.
11245275 - Descriptive analysis and quantification of angiogenesis in human brain tumors.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-5
Journal Detail:
Title:  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E     Volume:  -     ISSN:  1442-2050     ISO Abbreviation:  Dis. Esophagus     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8809160     Medline TA:  Dis Esophagus     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.
Affiliation:
Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immediate post-anaesthesia recovery 2013: Association of Anaesthetists of Great Britain and Ireland.
Next Document:  Agroinoculation of Beet necrotic yellow vein virus cDNA clones results in plant systemic infection a...